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Abstract 
To limit toxicity to normal tissues adjacent to the target tumour volume, radiotherapy is 
delivered using fractionated regimes whereby the total prescribed dose is given as a series of 
sequential smaller doses separated by specific time intervals. The impact of fractionation on 
out-of-field survival and DNA damage responses was determined in AGO-1522 primary 
human fibroblasts and MCF-7 breast tumour cells using uniform and modulated exposures 
delivered using a 225 kVp X-ray source. Responses to fractionated schedules (two equal 
fractions delivered with time intervals from 4 h to 48 h) were compared to those following 
acute exposures. Cell survival and DNA damage repair measurements indicate that cellular 
responses to fractionated non-uniform exposures differ from those seen in uniform exposures 
for the investigated cell lines. Specifically, there is a consistent lack of repair observed in the 
out-of-field populations during intervals between fractions, confirming the importance of cell 
signalling to out-of-field responses in a fractionated radiation schedule, and this needs to be 
confirmed for a wider range of cell lines and conditions. 
   
Introduction 
The differential radiobiological responses displayed by normal and tumor tissues exemplified 
by the five R’s of radiotherapy (Asur et al 2013), have led to the development of fractionated 
radiotherapy protocols where treatments are delivered as a series of equally sized fractions over 
a period of weeks. These treatment schedules are based largely on empirical observations and 
are currently being challenged as both hypo- and hyperfractionated schedules become 
increasingly common practice. 
Concurrently, there have been significant technological developments which have improved 
the conformality of dose to the tumor target whilst reducing dose in nearby normal tissue(Joiner 
and van der Kogel 2009). As a consequence, some areas outside of the primary treatment fields 
may experience steep dose gradients while others may receive a non-trivial dose bath due to 
scattered photons from multiple beams. 
Advanced radiotherapy techniques are currently being developed considering the spatio-
temporal changes which can affect the biological outcome. Incorporation of these 
radiobiological responses into the treatment planning to further improve treatment control 
demands new translational input.   
Radiation induced bystander signalling has been observed in a range of cell lines, tissue models 
and in vivo (Mancuso et al 2008) with an important characteristic being the dose-response 
relationship. It has been reported that the signal becomes saturated at a relatively low dose of 
irradiation (commonly below 1 Gy delivered to the target cells) and in many models, the low 
dose bystander response has been found to be almost equally effective as that of direct 
irradiation (Prise and O'Sullivan 2010, Mothersill and Seymour 2004).  
There have been extensive reports for the importance of bystander effects in vitro (Liu et al 
2006, Schettino et al 2005, Butterworth et al 2011) using for example precise microbeam 
approaches to selectively irradiate specific cells. More recently, experimental studies have 
investigated signalling effects using intensity modulated deliveries from medical linear 
accelerators (Suchowerska et al 2005, Mackonis et al 2007). Previous work (Ebert et al 2010, 
McMahon et al 2013a) has suggested that these effects are relevant not only out-of-field, but 
also contribute to survival of directly irradiated cells, emphasizing their relevance not only to 
organs at risk but also in tumour volumes. 
A recent model (McMahon et al 2013b) shows the predicted clinical relevance of intercellular 
communication in treatment planning by incorporating bystander signalling as part of the 
biological effective dose. The model predicts a significant difference in the signalling adjusted 
dose and physical dose for a large volume, with the highest impact for nearby organs at risk. 
Additionally, high dose regions will see a decrease in the biologically effective dose with 
significant differences (i.e., from 74 to 71 Gy) in IMRT plans. However, the model considers 
the radiation being delivered as a single acute dose and does not consider cell recovery and 
possible complications due to the intercellular signalling between fractions. 
Because of the well-established impact of fractionation in clinical settings and the increasing 
interest in alternative fractionation schedules, an understanding of the impacts of fractionation 
on intercellular signalling effects is important to understand the role these effects may have in 
advanced therapies. This study aims to address this need by determining the impact of dose 
fractionation on in- and out-of-field responses of DNA damage and survival. 
 
Materials and Methods 
Cell culture 
Experiments were conducted using two human cell lines, the breast adenocarcinoma cell line, 
MCF-7 and the transformed fibroblast cell line, AGO-1522. Cell lines were selected as 
malignant and transformed models with previously reported radiosensitivities and alpha/beta 
ratios. MCF-7 cells, obtained from Cancer Research UK, were maintained in Dulbecco’s 
Modified Eagle’s Medium (Sigma Aldrich, UK) supplemented with 10% fetal bovine serum 
(PAA Laboratories, UK) and 1% penicillin/streptomycin (Gibco-Invitrogen, UK). AGO-1552 
cells obtained from the Coriell Institute for Medical Research (Camden, NJ, USA) and 
maintained in α-modified Eagle’s Medium (Lonza, UK) supplemented with 20% fetal bovine 
serum (PAA Laboratories, UK) and 1% penicillin/streptomycin. All cell lines were maintained 
at 37°C in a humidified atmosphere of 5% CO2. 
 
Clonogenic survival assay 
Cell survival was determined by clonogenic assay as previously described (Trainor et al 
2012a). Cells were plated and allowed to adhere overnight before being irradiated with a single, 
acute exposure or two equally sized fractions separated by time intervals from 4 to 48 hours 
and incubated at 37°C between irradiations. Exposures were performed under uniform and 
shielded beam configurations. For the more radioresistant MCF-7 cell line, doses between 0-8 
Gy were used, while for the more radiosensitive cell line (AGO-1552) doses between 0-6 Gy 
were used. For each experiment, unexposed controls were prepared and treated as sham 
exposures. Experiments were conducted under standard culture conditions or in the presence 
of the free radical scavenger, dimethyl sulphoxide (DMSO, Sigma Aldrich, UK) at a 
concentration of 5% in culture media added 2 hours prior to irradiation and removed and 
replaced with complete culture medium 24 hours after irradiation. Cultures were incubated for 
10-14 days before staining with 0.5% crystal violet in 70% methanol. 
 
 
 
 
DNA damage analysis by immunofluorescence microscopy 
 
Cells were plated at a density of 1.5 x 105 cells onto microscope slides in P90 cell culture dishes 
and allowed to adhere overnight before being irradiated (acute or split exposure) with a total 
dose of 2 Gy separated by times ranging from 30 minutes to 24 hours. Exposures were 
performed under uniform and shielded beam configurations and cells fixed using 4% 
paraformaldehyde solution at time intervals up to 24 hours. DNA damage was quantified by 
immunofluorescence detection of γH2AX and 53BP1 as previously described (Trainor et al 
2012b). Nuclear foci were manually scored for 100 cells per slide using a Zeiss Axiovert 200 
M microscope (Carl Zeiss MicroImaging, LLC, USA).  
 
 
Irradiation setup and validation of experimental design 
 
As cellular responses to radiation exposure are determined by a variety of parameters including 
cell type, absorbed dose and irradiation time, a variety of irradiation scenarios have been set-
up on an X-RAD 225 kVp (Precision X-Ray) source with a dose-rate of 0.59 Gy/min. These 
included single and fractionated dose deliveries for uniform and shielded exposures.  
Each T25 flask (Nunclon surface NUNC) was aligned with the beam centre and for shielded 
exposures lead shielding (13.6 x 10.4 x 2.1 cm3 lead blocks MCP60-Mining & Chemical 
Products Ltd.) was positioned over half of the dish or flask, 2.8 cm above the cell layer. RTQA 
Gafchromic® film (Vertec Scientific Ltd.) was attached to the bottom of each flask in order to 
help repositioning the flask and monitoring the dose boundaries. When scoring the foci or 
colonies, an exclusion zone of 1 cm was defined around the dose fall-off region (as seen in 
figure 1). 
Ionisation chamber (PTW Freiburg) measurements were made in conjunction with film 
measurements to define the shielded and penumbra regions. The dose delivered to the out-of-
field region was estimated as the average scattered dose to that region. For a 50% modulated 
field the scattered dose received out-of-field was determined to be 3% of the total dose 
delivered to the in-field region. 
 
Data analysis 
For each of the clonogenic experiments, survival fractions were calculated as the ratio between 
the number of surviving colonies in the irradiated flask relative to the number of colonies in a 
sham irradiated flask normalized to the number of cells plated.  
The survival curves have been fitted using the linear quadratic model ݕ ൌ ݁ିఈ஽ିఉ஽మ where the 
αD term represents cell death due to complex single event hits, and βD2 is attributed to multiple 
track events; the out-of-field survival was fitted using a single exponential functionݕ ൌ ݕ௢ ൅
ܣ݁ି௔ௗ where d is the scattered dose under the shielding. Recovery kinetics for 8 and 6 Gy doses 
were fitted to the exponential decay function ݕ ൌ ܣ݁ି௧ ఒ⁄  where λ is the characteristic time. 
DNA damage analysis considered foci number relative to sham irradiated control numbers. The 
onset and repair curve for single dose irradiation was fitted to the following equation  
ݕ ൌ ܣሺ1 െ ݁ି௥௧ሻ݁ି௕௧ , where t is the incubation time after irradiation, r the rate at which foci 
appear, and b the DNA damage decay rate. The fractionated exposure foci decay curves for 
uniform field and in-field were fitted to the single phase exponential decay ݕ ൌ ݕ଴ ൅ ܣ݁ି௕௧భ 
where t1 is the time interval between the fractions, y0 is the number of foci induced by the 
second fraction, b the damage decay rate and A the number of foci from the first fraction.  
 All experiments were carried out in duplicate, on at least 3 separate occasions. The data is 
presented as ± standard error and corrected for the non irradiated controls.  
Data was fitted using Origin Pro 8.0 and statistical errors are calculated as the standard error 
of the mean. Statistical analysis for DNA damage experiments was carried out using Student’s 
t-test, and Mann-Whitney U test for cell survival data. Statistical significant differences were 
assumed at the level of p<0.05. 
 
 
Results 
Impact of fractionation on cell survival 
As seen in figure 2 both cell lines show an increase in cell survival after the fractionated 
uniform dose delivery when compared to acute exposure, even at the shortest time intervals (4 
hrs). The lack of further repair as inter-fraction time increases indicates repair processes with 
a short half-time have a stronger impact on the overall survival.  
Figures 3 and 4 show the effects of modulated field exposures both in- and out-of-field. The 
sparing effect on the directly irradiated cells is still present as previously reported for a single 
fraction (van den Aardweg 2003). The response of the out-of-field cells is independent of dose 
fractionation, with no evidence for either repair between fractions or a cumulative effect from 
multiple exposures; this behaviour is consistent in both cell lines.  
When using a free radical inhibitor such as DMSO the intercellular effects are abrogated in 
both cell lines. This is known (McMahon et al 2013a, Trainor et al 2012a) to attenuate the out-
of-field effects and the survival fraction increases to the one expected for scattered dose alone. 
This also has effects on the in-field sparing, thus causing the survival fraction in-field to follow 
a similar trend to the uniform field irradiation. 
As expected, fractionation has a significant effect on the beta component, (as seen in table 1). 
For AGO-1522, it decreases from 0.023 Gy-2 for acute dose delivery to 0 for split dose 
irradiation, while α has no significant variation. MCF-7 cells show a decrease in β from 0.064 
Gy-2 for single dose irradiation to 0.03 Gy-2 for split-dose irradiation. Within experimental 
uncertainties these observations agree with modelling fractionated exposures as 2 independent 
single fractions (which predict β for two-fraction exposures should be equal to a half that of a 
single exposure). Similar trends for α and β with dose fractionation have been reported 
elsewhere (van den Aardweg 2003). 
 
DNA damage repair following exposure to fractionated radiation 
 
Figure 5a shows reference DNA repair kinetics for both cell lines for 53BP1 DNA damage 
marker only following acute exposure with 2 Gy. The residual damage level at 24 h is 8.3±1.4 
and 5.6±0.89 foci per cell linked to a repair half time of 4.52±0.5 and 5.92±0.8 h for MCF7 
and AGO-1522 respectively.  
To assess how the inter-fraction time affects the DNA damage, contribution of the second 
fraction was kept constant by fixing the slides 30 minutes after the last irradiation. Figure 5b 
and c show the damage decay with half-lives of 4.07±0.5 h for MCF7 and 6.93± 0.8 h for AGO-
1522. For the same time points in modulated configuration the DNA damage has a half life of 
9.9 ±0.9 h for MCF7 and 0.5±0.12 h in AGO-1522 cell line (Figure 6). Table 2 shows the variation 
of the DNA damage decay rates and half-times. It is important to note that the repair half time 
for uniform field and cell survival data indicate the 4 h time interval is very important in cell 
recovery for the investigated cell lines.  
In both MCF-7 and AGO-1522 cells, no statistically significant difference was seen in DNA 
damage levels observed out-of-field with varying inter-fraction times. This suggests that no 
additional DNA damage accumulates after the delivery of the first fraction which is also 
consistent with the observed cell survival responses. 
 
Discussion 
Previous studies (Butterworth et al 2011, McMahon et al 2013a) highlighted the importance 
of intercellular signaling in modulated fields, showing that survival of directly irradiated cells 
depends not only on the physical dose but also on the dose the cells in the vicinity experience. 
It is clear that both the increase in cell death in the regions outside the primary radiation field 
and the increase in survival in the directly irradiated cells could have a potential impact in 
radiotherapy. 
Van den Aardweg et.al. (van den Aardweg 2003) investigated the effects of fractionated 
irradiation in primary and metastatic Human Uveal Melanoma cell lines using the clonogenic 
survival assay. Similar to the work presented here, the results indicated that fractionation had 
little influence on the α component. The overall enhancement of cell survival observed with 
dose fractionation was linked with repair of the sub-lethal DNA damage induced by the first 
dose, and expressed as the β component of the LQ model.  
Previous work from Mothersill et.al.(Mothersill and Seymour 2002) used the irradiated cell 
conditioned medium (ICCM) after fractionated exposure of donor cells to investigate the 
recovery pattern on recipient cells. Directly irradiated cells showed a significant recovery with 
dose fractionation, but recipient cells show no recovery with the dose split in two equal 
fractions by 3 hour time lapse. However, medium harvested from cells exposed to fractionated 
irradiation and added to non-irradiated cells reduced the survival below that seen for medium 
harvested from cells irradiated using a single-dose protocol. The authors reported that cells 
treated with media harvested from fractionated irradiation have a lower level of ‘recovery 
factors’ than those directly exposed to fractionated irradiation. This is consistent with the 
results presented here, pointing towards the lack of repair experienced by the out-of-field 
populations during variable inter-fraction exposure times.  
The recovery kinetics observed in this work are in agreement with previous reports (Mariotti 
et al 2013) showing that cells have largely recovered by 6 hours after the first irradiation event. 
Consequently, DNA damage induced by the second fraction is not enhanced by any residual 
damage, and cells react to it as a new single exposure.  
While fractionation has a significant effect on uniformly exposed populations, the overall 
survival is influenced by the intercellular signalling occurring in the modulated field exposures. 
The out-of-field populations have a different behaviour than the in-field cells at the DNA 
damage level, but this induces no significant change in the long term survival.  
When delivering the dose as two equal fractions, the out-of-field response has, as previously 
established (Schettino et al 2005), a binary behaviour, with populations of responding and non-
responding cells, reaching saturation at low out-of-field doses (<0.5 Gy). The lack of variation 
of the out-of-field responses with the inter-fraction interval suggests that the response is, as 
previously modelled (McMahon et al 2013a), related to the amount of time the signal is above 
a threshold value and not to the total signal exposure. 
The differing responses to fractionation between in- and out-of-field cells may have a 
significant impact on biological optimisation of fractionated radiotherapy. The effects of 
fractionation are typically understood through the partial or complete repair of sublethal 
damage with some characteristic half-life (T1/2) (Thames et al 1984).  
While these results are in agreement with this assumption for an individual exposure condition, 
they also suggest that, for the presented cell models, sublethal damage repair kinetics are not 
solely a function of a cell’s intrinsic radiosensitivity, but also on whether it is directly exposed 
to ionising radiation, subject to bystander stress, or a combination of both effects. This is a 
significant departure from established models, and may need to be incorporated in future 
radiobiological treatment planning models to fully understand and optimise the therapeutic 
ratio through parameters such as fraction size and margin prescription.  
 
 
 
Conclusion 
The impact of dose fractionation cannot be assessed in isolation but must consider the complex 
relationship between tumour radiosensitivity and the normal tissue tolerance to the late effects 
of radiation. The results in this work indicate that conclusions from directly irradiated repair 
kinetics cannot be extrapolated directly to populations that are primarily exposed to out-of-
field scattered radiation, as signalling-driven damage has significantly different kinetics. 
Considering the limitations of the model proposed here, further validation is required for a 
wider range of cell lines, different conditions, and in vivo, before their incorporation into robust 
treatment planning models as an important step towards the development of future biologically 
optimised treatment protocols.  
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 Figure 1. Schematic diagram of irradiation setup and the dose fall-out region at the field margin 
for a single fraction. Cells were seeded in T25 flasks and irradiated with the centre of the flask 
aligned with the shielding edge.   Dose profiles were measured by Gafchromic® film at different 
distances off axis after both fractions were delivered. Exclusion margin is set 1 cm around the 
dose fall-off region to account for the dose-step when repositioning the flask.  
 
 
Figure 2. Impact of dose fractionation on clonogenic survival for MCF-7 (a) and AGO-1522 
(c) cells following exposure to a uniform field configuration. Survival was calculated following 
acute single (solid line LQ fit) and total dose delivered as two equal fractions given 4h, 6h, 
24h, or 48h apart (dashed lines LQ model fit).*p≤0.05,**p ≤0.01.   b) and d) recovery kinetics 
for 8 and 6 Gy doses for MCF 7 and AGO-1522 respectively as a function of the time interval 
between deliveries (solid line is the fit according to  ݕ ൌ ܣ݁ି௧ ఒ⁄  where ߣ is the characteristic 
repair time). Error bars indicate ± standard error of the mean, n=3. 
  
Figure 3. Impact of dose fractionation on clonogenic survival for MCF-7 in- (a) and out-of-
field (c) cells following exposure to a modulated field configuration. Survival was calculated 
following acute single (solid line fit to LQ model) and total dose delivered as two equal 
fractions given 4h, 6h, 24h, or 48h apart ( dashed line fit to LQ model) .*p≤0.05,**p ≤0.01. 
The effect of the addition of the free radical scavenger DMSO for 4 Gy fractionated doses are 
shown in- and out of field in b) and d) respectively; e) recovery kinetics for 8 Gy  in-field 
survival as a function of the time interval between fractions, solid line is the fit according to  
ݕ ൌ ܣ݁ି௧ ఒ⁄  where ߣ is the characteristic repair time. Error bars indicate ± standard error of the 
mean, n=3. 
 
Figure 4. Impact of dose fractionation on clonogenic survival for AGO-1522 in- (a) and out-
of-field (c) cells following exposure to a modulated field configuration. Survival was calculated 
following acute single (solid line fit to LQ model) and total dose delivered as two equal 
fractions given 4h, 6h, 24h, or 48h apart ( dashed line fit to LQ model) .*p≤0.05,**p ≤0.01. 
The effect of the addition of the free radical scavenger DMSO for 4 Gy fractionated doses are 
shown in- and out of field in b) and d) respectively; e) recovery kinetics for 6 Gy  in-field 
survival as a function of the time interval between fractions, solid line is the fit according to  
ݕ ൌ ܣ݁ି௧ ఒ⁄  where ߣ is the characteristic repair time. Error bars indicate ± standard error of the 
mean, n=3. 
 
Table 1.  α and β parameters for AGO-1522 and MCF-7 for uniform field and exposed 
modulated field. 0h time point corresponds to single dose irradiation. Survival curve for 
uniform irradiation and modulated in-field were fitted by LQ model. 
Figure 5. DNA damage repair kinetics following exposure to a uniform radiation field after 
single dose (a) 53BP1 kinetics for both cell lines (MCF-7 solid line, AGO-1522 dashed line). 
Time points represent the incubation time after dose delivery. Kinetics following fractionated 
dose represented in (b) MCF-7 and (c) AGO-1522 solid line γH2AX, dashed line 53BP1. Foci 
numbers are corrected for sham-irradiated controls and a single phase exponential decay was 
used to fit the data. Time lapse indicates time between fractions; cells were fixed 30 minutes 
after the last dose delivery. Error bars indicate ± standard error of the mean, n=3. 
 Figure 6. DNA damage kinetics for 53BP1 following exposure to a modulated field and 
fractionated dose for (a) MCF-7 and (b) AGO-1522 cell lines; Solid line represents in-field 
repair and dotted line out-of-field kinetics. All cells were fixed 30 minutes after the last fraction 
was delivered. Foci numbers are corrected for sham-irradiated controls and data was fitted 
using a single phase exponential decay. Error bars indicate ± standard error of the mean, n =3 
Table 2. Fitting parameters for DNA damage decay curve for single dose uniform field and 
fractionated dose uniform and modulated fields. Supplementary table 2A contains the fitting 
parameters used in figure 4a. Table 2B shows the decay rates for DNA damage for 2Gy 
delivered as two equal fractions in uniform field or shielded configurations (Fig 5b and c and 
Fig 6). 
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Figure 4. 
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Table 1.   
Uniform Field MCF-7 AGO-1522 
Time lapse (h) α(Gy-1) β(Gy-2) α(Gy-1) β(Gy-2) 
0 0.29± 0.1 0.06± 0.03 0.71± 0.08 0.02 ±0.02 
4 0.27± 0.02 0.04 ±0.01 0.69± 0.07 0± 0.02 
6 0.26 ±0.03 0.04± 0.01 0.7± 0.08 0± 0.02 
24 0.26± 0.03 0.04± 0.01 0.65 ±0.05 0± 0.01 
48 0.29± 0.05 0.03± 0.01 0.64± 0.04 0± 0.01 
In-field                                               Modulated field 
0h 0.35± 0.1 0± 0.02 0.45± 0.06 0.02± 0.01 
4h 0.3 ±0.1 0± 0.01 0.46 ±0.01 0± 0.02 
6h 0.28± 0.02 0± 0.01 0.46± 0.07 0 ±0.01 
24h 0.2± 0.01 0± 0.06 0.49± 0.02 0± 0.01 
48h 0.2± 0.02 0± 0.01 0.43 ±0.08 0 ±0.01 
  
 
 
 
Figure 5.  
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Figure  6.  
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Table 2.  
 
 
 
 
 
Cell line DNA 
damage 
decay rate b 
(h-1 ) 
t1/2 repair half time 
from DNA damage 
repair 
(h) 
MCF-7 
single dose 
0.153±0.01 4.52±0.5 
AGO-1522 
single dose 
0.117±0.03 5.92±0.8 
Cell line y0(foci 
induced by 
the second 
fraction) 
A (foci 
induced by 
the first 
fraction) 
decay rate b 
(h-1) 
t1/2 repair half time 
(h) 
t1/2 recovery half time 
from survival 
recovery kinetics 
(h) 
MCF-7 
uniform 
22.43±4.4 17.48±4.16 0.17±0.03 4.07±0.5 4.06±1.08 
AGO-1522 
uniform 
17.42±5.4 18.59±5.28 0.10±0.05 6.93±0.8 4.94±0.2 
MCF-7 
exposed 
0.8±0.8 33.26±8.23 0.08±0.05 9.9±0.9 5.46±1.43 
AGO-1522 
exposed 
21.18±0.5 14.47±1.19 1.9±0.07 0.5±0.12 0.05±0.013 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
